ITMCTR2000003146尚未招募1 期
Mechanism and Clinical research of Zhenganxifeng dispensing granule decoction for treatment of hypertension with Yin Deficiency and Yang Hyperactivity Syndrome based on network pharmacology
Affiliated Hospital of Shandong University of TCM0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 75（—）
- 性别
- All
入选标准
- •1. it conforms to the diagnostic criteria of essential hypertension in western medicine and the diagnostic criteria of Yin deficiency and Yang hyperactivity syndrome of vertigo; Hypertension was grade 1, and was diagnosed as essential hypertension (grade 1) with Yin deficiency and Yang hyperactivity after standard lifestyle intervention;
- •2. In the past 2 weeks, blood pressure was stable, without the treatment of traditional Chinese medicine or proprietary Chinese medicine, after the treatment of western medicine, blood pressure was still in hypertension level 1 patients.
- •3. aged between 18 and 75 years old;
- •4. Volunteer to participate in the experiment and sign the informed consent, and cooperate with various investigations and tests.
排除标准
- •1. secondary hypertension, refractory hypertension, malignant hypertension, acute and subacute hypertension, white coat hypertension and unstable blood pressure;
- •2. pregnant and lactating women, women of child-bearing age do not agree to use contraceptive measures during the experiment;
- •3. Have mental illness, can't cooperate very well;
- •4. confirmed to have serious heart disease, severe neurosis and heart, liver, kidney insufficiency;
- •5. There are severe endocrine, hematopoietic system, liver, kidney and other primary diseases, malignant tumors, mental patients;
- •6. Uncorrected hyperthyroidism, hypothyroidism; Patients with nephrotic syndrome, diabetes mellitus and acute hepatobiliary disease;
- •7. people who have suffered from serious cerebrovascular accidents, heart diseases, severe trauma, major surgery and other primary diseases with unstable general conditions and poor prognosis within 6 months;
- •8. Complicated with other diseases and is receiving medication treatment.
研究者
相似试验
招募中
2 期
Study on the clinical mechanism of Tongxieanchangfang in the treatment of diarrheal irritable bowel syndrome based on single-cell sequencing technologyIrritable Bowel SyndromeITMCTR2100004327Dongfang Hospital Beijing University of Chinese Medicine
招募中
不适用
Clinical research of Xinglou Chengqi Decoction on improving post-stroke cognitive impairment due to phlegm heat and viscera excess syndrome based on brain-gut interactioPost-stroke Cognitive ImpairmentITMCTR2100004688Wenzhou Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Zhejiang University of Traditional Chinese Medicine
招募中
1 期
Shenan Tongluo decoction in treatment of diabetic kidney disease: Study protocol for a randomized Controlled trialDiabetic NephropathyITMCTR2100005191Changchun University of Chinese Medicine
招募中
1 期
A clinical study on the efficacy of Xuefu Zhuyu Decoction in acute radiation esophagitis in esophageal cancer radiotherapyITMCTR2100004685Affiliated Hospital of Nanjing University of Chinese Medicine
招募中
1 期
A Clinical Study of the Efficacy of Fuzhenghuayu Granules Combined with Losartan in the Treatment of Primary GlomerulonephritisChronic glomerulonephritis (CKD3 stage)ITMCTR2000003765Shuguang Hospital affillated with Shanghai University of TCM